Recent insider trading activity from Shearman Mark S, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2023 | Editas Medicine, Inc. | $EDIT | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2790 | $9.67 | 65,559.0000 | 0 | 4.08% | 0.00% |